13115-21-4 Usage
Description
HYDROXYGUANIDINE SULFATE is a member of the class of guanidines, specifically a guanidine compound in which one of the hydrogens attached to the nitrogen at position 1 is substituted by a hydroxy group. It is known to act as a substrate for dopamine β-hydroxylase, an enzyme involved in the biosynthesis of neurotransmitters.
Uses
Used in Pharmaceutical Industry:
HYDROXYGUANIDINE SULFATE is used as a pharmaceutical compound for its role in the biosynthesis of neurotransmitters. Its function as a substrate for dopamine β-hydroxylase makes it a potential candidate for the development of treatments related to neurotransmitter imbalances and associated conditions.
Used in Research and Development:
In the field of research and development, HYDROXYGUANIDINE SULFATE is utilized as a key compound for studying the mechanisms of neurotransmitter synthesis and the role of dopamine β-hydroxylase in various biological processes. This understanding can contribute to the advancement of therapeutic strategies for neurological and psychiatric disorders.
Used in Chemical Synthesis:
HYDROXYGUANIDINE SULFATE can also be employed as a starting material or intermediate in the synthesis of other guanidine-based compounds with potential applications in various industries, such as pharmaceuticals, agrochemicals, and materials science. Its unique structural features make it a valuable building block for the development of novel molecules with specific properties and functions.
Check Digit Verification of cas no
The CAS Registry Mumber 13115-21-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,1,1 and 5 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 13115-21:
(7*1)+(6*3)+(5*1)+(4*1)+(3*5)+(2*2)+(1*1)=54
54 % 10 = 4
So 13115-21-4 is a valid CAS Registry Number.
13115-21-4Relevant articles and documents
6-SUBSTITUTED DERIVATIVES OF HEXAMETHYLENE AMILORIDE AS INHIBITORS OF uPA AND USES THEREOF
-
Page/Page column 53, (2018/05/24)
The present invention broadly relates to 6-substituted derivatives of hexamethylene amiloride, the preparation thereof, and their use in the treatment of diseases such as cancer.
COGNITION ENHANCING COMPOUNDS AND COMPOSITIONS, METHODS OF MAKING, AND METHODS OF TREATING
-
Page/Page column 158, (2012/03/27)
The invention relates generally to muscarinic agonists, which are useful for stimulating muscarine, receptors and treating cognitive disorders. Included among the muscarinic agonists disclosed herein are oxadiazole derivatives compositions, and preparations thereof. Methods of synthesizing oxadiazole compounds also are provided. This disclosure also relates in part to compositions for enhancing cognitive function in subjects such as humans. The compositions comprising a muscarinic agonist or a pharma.ceutically suitable form thereof. This disclosure relates in part to methods of treating animals such as humans by administering such compositions.
COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING
-
Page/Page column 129, (2010/09/18)
Muscarinic agonists, which are useful for stimulating muscarinic receptors and treating cognitive disorders, are provided. Methods of synthesizing such agonists also are provided. Also provided are compositions for enhancing cognitive function in subjects such as humans, the compositions comprising a muscarinic agonist or a pharmaceutically suitable form thereof. Also provided are methods of treating animals such as humans by administering such compositions.
